Dr. Akinboro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Boston Medical Center
Section of Hematology/Oncology, FGH Building, 1st Floor
Boston, MA 02118- Is this information wrong?
Education & Training
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Chief Residency, Internal Medicine, 2016 - 2017- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2013 - 2016
University of Ilorin Faculty of Health SciencesClass of 2006
Certifications & Licensure
NY State Medical License 2017 - 2024
MA State Medical License 2017 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 7 citationsUS Food and Drug Administration Approval Summary: Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non-Small-Cell...Oladimeji Akinboro, Nicole Drezner, Anup Amatya, Jin Runyan, Jeanne Fourie-Zirkelbach, Miao Zhao, Youwei Bi, Kwadwo Korsah, Bronwyn Mixter, Shenghui Tang, Erin Larkins...> ;Journal of Clinical Oncology. 2023 Jun 10
- 31 citationsFDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as Single Agents for First-Line Treatment of Advanced/Metastatic PD-L1-High NSCLC.Oladimeji Akinboro, Erin Larkins, Lee H Pai-Scherf, Luckson N Mathieu, Yi Ren, Joyce Cheng, Mallorie H Fiero, Wentao Fu, Youwei Bi, Shyam Kalavar, Samina Jafri, Pallav...> ;Clinical Cancer Research. 2022 Jun 1
- 43 citationsFDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations, , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Clinical Cancer Research. 2021 Aug 3
- Join now to see all
Lectures
- Contemporary patterns of racial/ethnic disparities in surgical treatment and overall survival for localized resectable non-small cell lung cancer in the United States.2019 ASCO Annual Meeting - 6/1/2019
- E-cigarette use among patients of smoking-related cancers in the United States.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
Adding Chemotherapy to Immunotherapy Improves Survival in Advanced Non-Small Cell Lung CancerJune 5th, 2021
Secondhand Smoke Exposure in Cancer Survivors Remains HighSeptember 10th, 2017- Secondhand Smoke Exposure in Cancer Survivors Remains HighSeptember 10th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
